Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)
Authors:
Open Access
- 1 May 2017
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 76 (5) , 811-820
Abstract
Objectives Determine the efficacy and safety of daily lesinurad (200 or 400 mg orally) added to allopurinol in patients with serum uric acid (sUA) above target in a 12-month, randomised, phase III trial. Methods Patients on allopurinol ≥300 mg (≥200 mg in moderate renal impairment) had sUA level of ≥6.5 mg/dL (≥387 µmol/L) at screening and two or more gout flares in the prior year. Primary end point was the proportion of patients achieving sUA level of Results Patients (n=610) were predominantly male, with mean (±SD) age 51.2±10.90 years, gout duration 11.5±9.26 years and baseline sUA of 6.9±1.2 mg/dL (410±71 µmol/L). Lesinurad at 200 and 400 mg doses, added to allopurinol, significantly increased proportions of patients achieving sUA target versus allopurinol-alone therapy by month 6 (55.4%, 66.5% and 23.3%, respectively, pConclusion Lesinurad added to allopurinol demonstrated superior sUA lowering versus allopurinol-alone therapy and lesinurad 200 mg was generally well tolerated in patients with gout warranting additional therapy. Trial registration number NCT01493531.Keywords
This publication has 41 references indexed in Scilit:
- The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortalityBMC Nephrology, 2013
- Renal Transport of Uric Acid: Evolving Concepts and UncertaintiesAdvances in Chronic Kidney Disease, 2012
- 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemiaArthritis Care & Research, 2012
- Gout and the risk for incident heart failure and systolic dysfunctionBMJ Open, 2012
- Hyperuricemia and the risk for subclinical coronary atherosclerosis - data from a prospective observational cohort studyArthritis Research & Therapy, 2011
- Uric Acid and Cardiovascular RiskNew England Journal of Medicine, 2008
- Analytical approaches to reporting long-term clinical trial dataCurrent Medical Research and Opinion, 2008
- British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of GoutRheumatology, 2007
- Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injuryCritical Care, 2007
- Preliminary criteria for the classification of the acute arthritis of primary goutArthritis & Rheumatism, 1977